Rtw Investments, LP Akero Therapeutics, Inc. Put Options Transaction History
Rtw Investments, LP
- $6.23 Billion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AKRO
# of Institutions
193Shares Held
74.2MCall Options Held
429KPut Options Held
591K-
Janus Henderson Group PLC London, X06.12MShares$137 Million0.09% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$117 Million3.09% of portfolio
-
Wellington Management Group LLP Boston, MA5.21MShares$117 Million0.02% of portfolio
-
Black Rock Inc. New York, NY4.89MShares$109 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.06MShares$90.9 Million0.01% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $1.04B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...